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Abstract
Stress elicits the release of glucocorticoids (GCs) that regulate energy metabolism and play a role in emotional
memory. Astrocytes express glucocorticoid receptors (GR), but their contribution to cognitive effects of GC’s action in
the brain is unknown. To address this question, we studied how astrocyte-speciﬁc elimination of GR affects animal
behavior known to be regulated by stress. Mice with astrocyte-speciﬁc ablation of GR presented impaired aversive
memory expression in two different paradigms of Pavlovian learning: contextual fear conditioning and conditioned
place aversion. These mice also displayed compromised regulation of genes encoding key elements of the glucose
metabolism pathway upon GR stimulation. In particular, we identiﬁed that the glial, but not the neuronal isoform of a
crucial stress-response molecule, Sgk1, undergoes GR-dependent regulation in vivo and demonstrated the
involvement of SGK1 in regulation of glucose uptake in astrocytes. Together, our results reveal astrocytes as a central
element in GC-dependent formation of aversive memory and suggest their relevance for stress-induced alteration of
brain glucose metabolism. Consequently, astrocytes should be considered as a cellular target of therapies of stress-
induced brain diseases.
Introduction
Stressful events leave emotional memory traces that
enable adaptation of the animal to novel conditions1,2.
Emotional memories persist longer than memories of
neutral events and rely on the interaction between several
brain regions, including hippocampus and amygdala3. In
extreme cases, the exposure to stress may turn into dis-
ease, for example post-traumatic stress disorder (PTSD)
or depression1–3.
Cognitive effects of stress are largely mediated by glu-
cocorticoid hormones (GCs) whose release is controlled
via the hypothalamus−pituitary−adrenal (HPA) axis4,5.
GCs exert their action through their glucocorticoid
receptors (GR)6–9, which are uniformly distributed across
cell types and regions of the central nervous system (CNS)
and which regulate gene transcription10,11. Genetic var-
iants of GR and GR-dependent genes have been linked to
susceptibility to stress-related diseases and they have been
shown to predict the outcome of antidepressant treat-
ment12–14. Detailed understanding of how GR contributes
to stress-induced brain dysfunction may hence lead to
more successful therapeutic strategies for stress-induced
disorders.
The key question is which cells participate in GR-
dependent formation of stress-induced memories. Cell-
speciﬁc GR elimination revealed a crucial role of neurons
in the hippocampus, amygdala, and other brain areas15–18.
The role of astrocytes, which represent a major cell type
© The Author(s) 2018
OpenAccessThis article is licensedunder aCreativeCommonsAttribution 4.0 International License,whichpermits use, sharing, adaptation, distribution and reproduction
in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if
changesweremade. The images or other third partymaterial in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to thematerial. If
material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Correspondence: Michal Slezak (slezak@if-pan.krakow.pl) (slezak@bio.mx)
1Department of Molecular Neuropharmacology, Institute of Pharmacology,
Polish Academy of Sciences, Cracow 31-343, Poland
2Team Brain Microcircuits in Psychiatric Diseases, BioMed X Innovation Center,
Heidelberg 69120, Germany
Full list of author information is available at the end of the article.
These authors contributed equally: Magdalena Tertil, Urszula Skupio.
12
34
56
78
90
()
:,;
12
34
56
78
90
()
:,;
1
2
3
4
5
6
7
8
9
0
()
:,;
12
34
56
78
90
()
:,;
in the brain, has not been studied, despite the relevance of
GR signaling in astrocytes for psychiatric conditions has
been suggested in a survey of transcriptional changes
elicited by psychoactive compounds19. Astrocytes express
GR and respond to GR stimulation with increased intra-
cellular calcium concentrations and alterations of their
transcriptional and metabolic proﬁles20–27. Recent
research shows that glial metabolic activity involving
glucose uptake, glycogenolysis and lactate release is
indispensable for memory formation28–30. In our previous
work26 we showed that GR activation in astrocytes leads
to upregulation of two protein kinases known to regulate
metabolism, namely the pyruvate dehydrogenase kinase-4
(PDK4) that controls entering of glucose into the citric
acid cycle and serum and glucocorticoid-regulated kinase-
1 (SGK1), a protein associated with PTSD and depres-
sion31. Due to its clinical relevance, several studies
explored the function of SGK1 in neurons31,32, while the
role of this protein in glial cells remains poorly recog-
nized, despite demonstrated GR-dependent regulation26.
Here, we set out to explore whether GR signaling in
astrocytes contributes to emotional memory. We used a
transgenic approach to selectively eliminate GR from
astrocytes in the adult mouse brain and we evaluated the
impact of this genetic manipulation on the behavioral
outcome in classical paradigms known to rely on the
intact GC signaling: fear conditioning33 and conditioned
place preference or aversion34,35. Furthermore, we
explored the molecular basis of GC regulation of astrocyte
metabolism as a potential mechanism relevant for
observed behavioral effects.
Materials and methods
Animals and drug administration
All experiments were approved by II Local Ethics
Committee of Institute of Pharmacology. Mice were
housed 3–5 per cage in rooms with a controlled tem-
perature of 21 ± 2 °C under a 12/12 h light−dark cycle
with free access to food and water. Mice for selective,
inducible elimination of GR from astrocytes (GRastroKO)
were obtained by breeding a Cre-driver line expressing
tamoxifen (TAM)-inducible version of Cre recombinase
under the promoter of astrocyte-speciﬁc gap junction
protein, connexin−30 (Tg(Gjb6-CreERT2)T53–33Fwp)36,
with the transgenic line carrying critical exons of gene
encoding the glucocorticoid receptor (Nr3c1) ﬂanked by
loxP sites (Nr3c1tm2Gsc line8). Animals were bred on
C57Bl/6J background and genotyped as previously
described8,36. In bigenic mice administration of TAM
shall lead to excision of the loxP-ﬂanked genomic ele-
ments exclusively in subpopulation of cells expressing
CreERT2, with the efﬁciency of recombination depending
on the brain region (as the activity of the connexin-30
promoter driving CreERT2 varies across the brain) and the
availability of TAM. A minimal number of mice to ensure
experimental groups (designed based on pilot studies)
were put in mating and all male littermates were used in
experimental cohorts, randomly assigned to experimental
groups. No animals were excluded from the analysis.
Experimenters were blinded to the genotype of the ani-
mals during experiments and when assessing the
outcome.
Tamoxifen and dexamethasone (DEX) treatment
Experimental male mice of 8–10 weeks were treated
once daily for 5 days with TAM (Sigma, 100 μl of 20 mg/
ml in sunﬂower oil). Behavioral experiments were initi-
ated at least 3 weeks after the TAM injection to ensure
efﬁcient elimination of the GR protein37. For biochemical
tests animals were injected i.p. with 4 mg/kg DEX (Dex-
aven, JELFA S.A.) or saline.
Shock application and test of conditioned fear
The fear conditioning procedure was performed as pre-
viously described38. Brieﬂy, the test comprised two parts:
training and retrieval. In the contextual fear conditioning
paradigm, the training lasted 7min 10 s and consisted of a 2-
min acclimation to an automated shock chamber (Ugo
Basile, Comerio, Italy), followed by the application of ﬁve
foot shocks (1mA, 2 s each). The 1mA current was selected
based on a pilot study, in which WT mice displayed freezing
behavior for approx. 50% of time upon exposure to the
context 24 h after the training. Shocks were separated with
1min intervals, during which freezing behavior (deﬁned as
immobility, except for respiratory movements) was recorded
with charged coupled device camera (The Imaging Source,
Germany). In cue fear conditioning paradigm, the shock was
applied during the last 2 s of 20-s tone (60 dB) presented to
mice ﬁve times with a 1-min interval. After the training
animals were kept separately until all mice from the
homecage have completed training. For contextual fear
conditioning, at 1, 3, 5, or 7 days after training, mice were
placed in the same chamber as during the training. Freezing
behavior was measured for 3min in each retrieval session.
External conditions (odor, lighting, and time of day)
remained unaltered throughout the duration of the tests. For
cue fear conditioning, at the same timepoints the animals
were moved into a different context (different cage ﬂoor and
walls, different scent) and were presented with the same tone
as during training sessions, and the expression of cue-
induced fear memory was measured as freezing during
3min of the tone presentation. The freezing data were
analyzed using ANY-maze software (Stoelting, Wood Dale,
IL, USA).
Nociception
Tail ﬂick was performed using analgesia meter (Ugo
Basile, Italy). The light beam was applied to animals’ tail
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and the latency to tail withdrawal or shaking was recor-
ded. To avoid tissue damage, a cut-off latency was set at
9 s. Hot plate test was conducted using Hot Plate
Analgesia Meter (COTM, Bialystok, Poland). The mice
were placed on the plate heated to 52.5 °C and the latency
to the ﬁrst reaction (rapid reﬂexive retraction of the paw
or licking/biting of the paw) was measured. To avoid
tissue damage, a cut-off latency was set at 30 s.
Open ﬁeld
Mice were placed in an open ﬁeld arena (40 × 40 cm)
equipped with photocells (Med Associates, St. Albans,
VT, USA). Horizontal activity was measured in 30-min
sessions.
Light/dark box test
Each mouse was placed in the middle of the compart-
ment of the two-part apparatus (20 × 20 × 14 cm each)
made of black Plexiglas, lit by a dim light (50 lux). The
other compartment was made of white Plexiglas and was
illuminated with a lamp (300 lux). The 5-min trials were
video-recorded and analyzed using ANY-maze software
(Stoelting Co., Wood Dale, IL, USA). We measured the
number of transitions between compartments, the latency
to enter the illuminated compartment, and the total time
spent therein.
Novel object recognition test
The objects to be discriminated were a plastic toy
(2–2.5 cm diameter) and a plastic dice (2 cm). Animals
were habituated to the open ﬁeld for 30 min, during
locomotor activity test. The next day, they were indivi-
dually placed for 10 min (acquisition) in the open ﬁeld in
the presence of object A placed in one of the two pre-
sentation positions (in the corner, 5 cm from side walls).
The exploration time of object A (i.e. when the animal’s
snout was directed toward the object at a distance <
1 cm) was manually recorded. Twenty-four hours later
the animals were tested in the 10-min retention trial. A
recognition index was deﬁned as [tB/(tA+ tB)] × 100,
where tB/tA indicate the times the mouse spent
exploring the objects B/A, respectively. The type of
objects and their positions of presentation during the
acquisition and retention phases were counterbalanced
across animals.
Saccharin preference test
Mice were individually housed for 24 h and given a free
choice between two bottles containing tap water or 0.1%
saccharin solution. To avoid the possible effects of side
preference in drinking behavior, the position of the bottles
was changed after 12 h. The preference for saccharin was
calculated as a percentage of saccharin solution compared
to the total amount of liquid consumed.
Tail suspension test
Mice were suspended by the tail with adhesive tape
from an aluminum bar that was set at a height of 30 cm
from the ground. The total duration of immobility was
calculated over 6 min.
Conditioned place preference/aversion (CPP/CPA)
On day 1 (preconditioning) mice were placed in the
conditioning boxes for 20min and allowed to freely
explore the apparatus. On days 2–4 (conditioning), mice
were treated with alternating injections of saline in the
morning sessions and morphine (5 mg/kg) or naloxone
(10 mg/kg) during afternoon sessions. Immediately after
the injection mice were conﬁned to one of the two
compartments of the two-chamber box, for 40 min. On
day 5 (drug-free test) the mice were allowed to explore the
whole apparatus without any treatment and the time
spent in the drug-paired compartment was measured.
Immunoﬂuorescence
Animals were perfused with 4% paraformaldehyde
(PFA) buffered with phosphate buffered saline (PBS),
brains were postﬁxed in 4% PFA and stored in PBS. Serial
40-μm-thick coronal sections from CTRL and GRastroKO
mice obtained with vibratome were processed in parallel.
Free-ﬂoating sections were rinsed in PBS, incubated with
10% normal goat serum in PBS with 0.2% Triton X−100
(PBS-Tx) for 90min at room temperature (RT) and
incubated overnight at RT with antibodies: polyclonal
anti-S100β (1:250, 287004, Synaptic Systems) or a
monoclonal anti-NeuN (1:200, MAB377, Merck Milli-
pore) and a monoclonal anti-GR (1:100, 12041 S, Cell
Signalling) diluted in PBS-Tx containing 1% normal
serum. The next day, sections were washed in PBS and
incubated for 90 min at RT with ﬂuorophore-conjugated
secondary antibodies (A11073 and A11036, Thermo-
Fisher), diluted 1:250 in PBS-Tx containing 1% normal
serum. Afterwards, sections were washed, incubated for
10min at RT with Hoechst (1:2000 dilution in PBS,
H3570, ThermoFisher), washed and embedded in Pro-
Long Diamond Antifade Mountant (P36965, Thermo-
Fisher). Imaging was performed with a ﬂuorescent
confocal microscope (Nikon A1R). The contrast and
brightness were altered for illustration purposes in FIJI39.
Co-expression of GR with S100β or NeuN was deter-
mined in individual confocal sections of hippocampal
CA1 area, prefrontal cortex (PFC) and amygdala using
Synchronize Windows and Cell Counter plugins.
Magnetic beads-based sorting of astrocytes
Hippocampi from two animals were pooled and lysed
into single-cell suspension using Neural Tissue Dissocia-
tion Kit (T) (Miltenyi Biotec) on GentleMACS Dis-
sociator. Next, samples were depleted of myelinating cells
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on LS columns (Miltenyi Biotec) using Myelin Removal
Beads II (Miltenyi Biotec). Astrocytes were isolated
(Suppl. Figure 1) on MS columns using Anti-Glast
Microbead Kit (Miltenyi Biotec). Flow-through from the
columns was also collected and analyzed in parallel. RNA
was isolated using RNAeasy Micro Kit (Qiagen) and
reverse-transcribed into cDNA using Superscript III
Reverse Transcriptase (Invitrogen).
Gene expression analysis
Dissected CNS structures were immersed in RNAlater
solution (Qiagen) and stored in −70 °C until isolation.
Tissues were homogenized in Trizol reagent (Life Tech-
nologies) using TissueLyser (Qiagen). Primary cells were
harvested in Trizol. Total RNA (500–1000 ng) was
reverse-transcribed into cDNA using Omniscript RT Kit
(Qiagen). cDNA corresponding to 5–10 ng of total RNA
was used for qPCR utilizing TaqMan Universal PCR
Master Mix (Applied Biosystems) and commercial Taq-
Man probes (Applied Biosystems) as well as Assay-On-
Demand probes (Applied Biosystems) for different Sgk1
variants: Sgk1_002 encoding a neuron-speciﬁc isoform40,
Sgk1_003 and a canonical isoform Sgk1_001, the latter two
enriched in glial cells26. Assays were run on the iCycler
(Bio-Rad). Data were calculated according to ΔCt method,
using Actb or Hprt as reference genes. Fold change of
DEX-induced gene expression was calculated and pre-
sented as a ratio over SAL-induced expression.
Protein expression analysis
Cells were scraped in ice-cold PBS and lysed in RIPA
buffer. Thirty-50 μg of protein extract was resolved
according to standard SDS-PAGE protocol and trans-
ferred onto a nitrocellulose membrane (Protran). Detec-
tion was accomplished with anti-SGK1 (ab59337, Abcam)
and anti-β-actin (A5441, Sigma) antibodies, resolved with
respective secondary antibodies (PI-1000 and PI-2000,
Vector Laboratories). Chemiluminescent signal was col-
lected using LAS 4000 Luminescence Image Analyzer
(Fuji).
Primary cultures, viral transduction, and drug treatment
in vitro
Brain hemispheres were dissected from 5–7-day-old
C57Bl/6N mice and dissociated into a single-cell sus-
pension using Neural Tissue Dissociation Kit (T) (Milte-
nyi Biotec). Cells were isolated by magnetic sorting using
Anti-Glast Microbead Kit and MS Columns (Miltenyi
Biotec), seeded on polyornithine (Sigma-Aldrich)-coated
dishes and cultured in Dulbecco's modiﬁed Eagle medium
αemented with 10% fetal bovine serum and penicillin/
streptomycin under 5% CO2 at 37 °C for 7–10 days, when
they were re-plated for experiments. After reaching con-
ﬂuence, cells were grown in serum-free medium for 24 h
and stimulated with 100 nM dexamethasone (Sigma) for
4 h or 24 h. For lentiviral vector (LV)-mediated gene
knockdown, astrocytes were incubated overnight with
LV-shRNA particles at multiplicity of infection= 75 in
the presence of 4 μg/ml polybrene (Sigma). Experiments
started 72 h post-infection. Details of LV production are
provided in Supplementary Methods.
In vitro assays
Metabolic assays were performed using Glucose Uptake
Assay Kit, L-Lactate Assay Kit, and Glycogen Assay Kit (all
Abcam) according to the vendor’s protocol. Fluorescence
was measured using Tecan Inﬁnite m1000 Pro microplate
reader.
Statistical analyses
Normality and homogeneity of variance were examined
using Shapiro−Wilk and Levene tests, respectively. Fol-
lowing Student’s t test or two-way ANOVA were applied
where appropriate. Two-way ANOVA and post-hoc tests
were performed using lm, lme, and emmeans functions (R
Core Team, 2018). Full statistical analysis is provided in
Supplementary Table.
Results
Characterization of a transgenic mouse model to study the
role of GR signaling in astrocytes
To test whether astrocyte-speciﬁc GR signaling con-
tributes to GR-dependent cognitive effects, we employed a
conditional knockout strategy. We selectively eliminated
GR from astrocytes by administering tamoxifen (TAM) to
offspring originating from breeding the transgenic line
carrying TAM-inducible version of Cre recombinase
driven by the astrocyte-speciﬁc promoter36 with the
transgenic line carrying critical exons of the Nr3c1 gene,
encoding GR, ﬂanked by loxP sites8 (Fig. 1a). We named
bigenic, TAM-treated mice GRastroKO, while monogenic,
TAM-treated mice were used as a control (CTRL). To test
for the efﬁciency of recombination we performed immu-
nohistochemical examination of the expression of GR in
astrocytes in sections collected from CTRL and GRastroKO
mice (Fig. 1b). This analysis revealed that in several brain
regions relevant for emotional memory, namely hippo-
campus, prefrontal cortex (PFC) and amygdala all astro-
cytes in CTRL mice expressed GR (Fig. 1c). In contrast, in
sections from GRastroKO mice the fraction of astrocytes
expressing GR halved in the hippocampus, while in the
PFC and amygdala the recombination efﬁciency was lower
(Fig. 1c). To test for the speciﬁcity of GR elimination we
checked for a fraction of NeuN-positive neurons expres-
sing GR and, as expected, no changes were detected
between CTRL and GRastroKO groups (Suppl. Figure 2).
The speciﬁc elimination of GR was further conﬁrmed by
observation that the abundance of the Nr3c1 transcript
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approximately halved in astrocytes, but not in the mix of
other cell types isolated from hippocampi of GRastroKO
mice, as compared to CTRL mice (Fig. 1d). The functional
efﬁciency of our intervention was evaluated by measuring
the abundance of a bona ﬁde GR transcriptional target,
Tsc22d3, in several regions of the CNS collected 4 h after
i.p. injection of a GR agonist, dexamethasone (DEX, 4 mg/
kg) or saline (Fig. 1e). We found that DEX-induced
increase of Tsc22d3 was diminished in GRastroKO as
compared to CTRL mice in homogenates of spinal cord,
hypothalamus, hippocampus, and amygdala, but not in
the PFC and striatum.
Taken together, these data indicate that our strategy led
to the efﬁcient elimination of GR from astrocytes in the
hippocampus, with lower efﬁciency in amygdala and PFC.
Simultaneously, we identiﬁed astrocytes as a direct and
prominent cellular target of GR transcriptional activity in
the CNS of adult mice.
Astrocyte-speciﬁc elimination of GR impairs fear memory
Equipped with the tool, we asked whether astrocytic
GR signaling is involved in emotional memory. To
answer this question, we exposed CTRL and GRastroKO
mice to contextual fear conditioning paradigm, which
relies on the intact hippocampal network, where GR
ablation from astrocytes in GRastroKO was robust. Mice
were habituated to the apparatus for 2 min before
receiving ﬁve consecutive foot shocks (see Methods). The
freezing time measured during the training sessions was
similar in both groups (Fig. 2a). Together with the fact
that the nociception of GRastroKO mice did not differ from
the CTRL mice (Fig. 2c, d), these data conﬁrmed even
sensory stimulation in both groups. We measured con-
ditioned fear memory in four retrieval sessions, starting
from 24 h and spaced with 48 h intervals. As expected,
both groups displayed progressive shortening of freezing
time upon repetitive exposure to the fear context. How-
ever, two-way repeated measures ANOVA revealed a
major effect of genotype (F(1,30)= 19.58, p < 0.001) and
time (F(3, 90)= 17.31, p < 0.001), but not the interaction
of the two factors on the freezing behavior. Signiﬁcant
differences between the CTRL and GRastroKO group were
detected at every timepoint tested (Fig. 2b). Importantly,
in a series of control experiments we excluded the pos-
sible effects of the mutation on several behavioral para-
meters that may confound the interpretation of these
results. GRastroKO mice were indistinguishable from the
CTRL group with respect to their locomotor behavior
(Fig. 2e, f) and anxiety (Fig. 2g, h). We did not detect
deﬁcits in 24 h memory of a neutral event (Fig. 2i) nor in
working memory (Fig. 2j). Moreover, our genetic manip-
ulation did not elicit depressive-like symptoms, because
performance in the tail suspension test (Fig. 2k) and
sucrose preference test (Fig. 2l) did not differ between the
two groups. The speciﬁc role of hippocampal astrocytes in
contextual fear memory formation was highlighted by the
fact that we did not detect differences between the CTRL
and GRastroKO groups in the cue fear conditioning para-
digm (Suppl. Figure 3), which relies on intact amygdala (a
brain region where GR elimination from astrocytes was
minor).
These data reveal that astrocyte-speciﬁc GR signaling is
involved in fear memory.
Astrocyte-speciﬁc elimination of GR prevents aversive
memory formation
Next, we asked whether astrocytic GR signaling is
relevant for emotional memories of opposite valence. To
examine that, we used two paradigms of Pavlovian con-
ditioning where animals learn to associate the exposure to
an appetitive or aversive drug with a speciﬁc compart-
ment of the two-chamber box. CTRL and GRastroKO mice
could freely explore the two-compartment box for 20 min
on day 1 of the procedure. On days 2–4 they received i.p.
administration of saline, morphine (MOR) or naloxone
(NAL) and immediately after the injection they were
placed for 40min in the compartment paired with the
drug. On the test day mice were allowed to explore the
entire apparatus and we measured the time that they
spent in the drug-associated compartment. Two-way
ANOVA (type 3) revealed the signiﬁcant effect of the
treatment (F(2, 83)= 17.76, p < 0.001) and genotype ×
(see ﬁgure on previous page)
Fig. 1 Characterization of a transgenic mouse model for astrocyte-speciﬁc elimination of GR. a Top: schematic representation of the
expression of Nr3c1 gene (encoding GR) in astrocytes (active Cx30 promoter) or other cells (inactive Cx30 promoter) in bigenic mice carrying Cx30-
CreERT2 and GRlox/lox alleles. Bottom: experimental timeline. b Confocal microphotographs containing single optical slices collected from
hippocampal sections from CTRL (left) and GRastroKO (right) mice after immunohistochemical staining against GR (red), an astrocytic marker s100β
(green) and nuclear counterstain with Hoechst (blue). Side panels contain orthogonal views of confocal stacks at indicated sites. c Bar plot
summarizing the fraction of s100β-positive astrocytes displaying GR immunoreactivity in sections of indicated brain regions obtained from CTRL (gray
bars, n= 1937 astrocytes) and GRastroKO (blue bars, n= 1785 astrocytes) mice (n= 4 per group). HIP hippocampus, AMY amygdala, PFC prefrontal
cortex. d The abundance of Nr3c1 normalized to Actb in the puriﬁed hippocampal astrocytes and ﬂow-through from the MACS column (see
Methods) obtained from CTRL and GRastroKO mice measured with qPCR. e The abundance of Tsc22d3, normalized sample-wise to Actb and
normalized to the expression in CTRL mice receiving SAL, examined with qPCR in homogenates of prefrontal cortex (PFC), striatum (STR), amygdala
(AMY), hippocampus (HIP), hypothalamus (HTH) and spinal cord (SC) collected from CTRL (n= 4) and GRastroKO (n= 5) mice 4 h after administration of
DEX (4 mg/kg). Mean ± SEM, *p < 0.05, **p < 0.01, ***p < 0.001, t test
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treatment interaction (F(2,83)= 4.21, p < 0.05), but not of
the genotype on the time that animals spent in a drug-
paired compartment. Detailed analysis revealed that both
groups developed conditioned place preference (CPP) to
morphine to a similar degree (Fig. 3). In contrast, condi-
tioned place aversion (CPA) to naloxone has developed
only in the group of CTRL mice, but not in GRastroKO
mice (Fig. 3).
Together with the results of fear conditioning, these
data indicate the crucial role of astrocyte-speciﬁc GR
signaling in aversive memory.
Glucocorticoid signaling regulates metabolic status of
astrocytes
Since astrocytes are known to provide metabolic support
for neurons in memory formation and glucocorticoids are
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spent in (g) or latency to enter (h) the light compartment of the light−dark box; neutral 24 h memory assessed in the novel object recognition test
(i); working memory assessed with Y-maze test (j); depressive-like behavior assessed by total immobility time in the tail suspension test (k); anhedonia
assessed in a sucrose preference test (l). Mean ± SEM, t test
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powerful modulators of metabolic processes, we next
explored how GCs affect metabolic status of astrocytes
in vivo. We treated CTRL and GRastroKO mice with DEX,
sacriﬁced animals after 2 or 4 h, isolated hippocampal
astrocytes and measured the transcriptional proﬁle of
several metabolically relevant genes. We observed the
induction of the canonical isoform of Sgk1 (Sgk1_001),
followed by the activation of Pdk4 and a glucose trans-
porter 1 (Slc2a1) after 4 h of DEX treatment. All GR-
induced effects were abolished by astrocyte-speciﬁc abla-
tion of GR (Fig. 4a). We also conﬁrmed that the acute
stress, namely exposure to quintuple foot shock, elicited in
the hippocampus an increase in the expression of two
isoforms of Sgk1 known to be enriched in glial cells,
namely Sgk1-001 and Sgk1-003, but not of the neuron-
speciﬁc isoform Sgk1_002 (Fig. 4b). Since SGK1 is a known
GR-dependent kinase regulating cellular metabolism, we
went on to investigate which processes rely on its intact
expression in astrocytes. We found that knockdown of
Sgk1 in primary astrocytes (Suppl. Figure 4) affected glu-
cose uptake but did not alter basal nor DEX-induced
lactate release or glycogen content (Fig. 4c). Hence, we
identiﬁed SGK1 as a regulator of glucose uptake in
astrocytes.
These data uncover tight regulation of astroglial meta-
bolic status by GCs.
Discussion
Stress-induced GCs mediate its adaptive roles, including
the emotional memory1,2. Decades of research revealed a
variety of neuronal and synaptic actions of GCs, mediat-
ing its cognitive effects in the brain41. We show that non-
neuronal cell type, astrocytes, is also an important locus of
this action. Our results argue that astrocytes are a direct
and prominent locus of GR transcriptional activity in the
nervous system. Our new genetic model enables further
investigation of the effects of acquired loss of GR in
astrocytes and examination of astrocytic pathways rele-
vant for the observed behavioral effects.
Our data recapitulate the inhibition of conditioned fear
memory resulting from lesions of hippocampus42, as well
as pharmacological blockade of GR activation in the
hippocampus43. Likewise, our results mimic the negative
effect of adrenalectomy on the development of CPA35.
Due to objective reasons, above-mentioned studies did
not allow to specify a cellular effector of GR signaling in
these regions. We conclude that, besides the described
involvement of the neuronal compartment18, astrocytes
are an overlooked cellular site mediating GCs effects on
aversive memory. In contrast, we did not observe the
effect of the mutation on morphine-induced CPP. One
explanation for these data is that GR signaling in neurons
mediates appetitive action of abusive compounds, like
cocaine44, while the glial GR signaling is dispensable for
that aspect. An alternative explanation comes from the
fact that in our model GR was not eliminated from several
brain regions implicated in appetitive memory, like the
striatum. Therefore, we cannot rule out that the role of
astrocytic GR in appetitive memory could not be detected
in this study due to the properties of the transgenic
model36.
The stage of the aversive memory affected in the study
remains speculative, because in our model astrocytes lack
GR before the ﬁrst exposure to the stressor. Our results
speak against an impaired acquisition, since we observed
identical increase of freezing response to consecutive
shock exposures in the training phase of the fear con-
ditioning and no deﬁcits in working memory in GRastroKO
mice. More probable is the impact on consolidation or
reconsolidation, occurring several hours after exposure to
stress45. This notion is supported by the fact that most of
GR-dependent astrocytic transcripts are characterized by
relatively long mRNA half-lives19, corresponding to
experience-dependent synaptic rearrangements. Astro-
cytes have long been considered to contribute to
Conditioned place preference / aversion
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#
Fig. 3 Astrocyte-speciﬁc elimination of GR blocks conditioned
place aversion. Comparison of the total time spent in the
compartment paired with administration of saline (SAL), morphine
(MOR) or naloxone (NAL) between CTRL (gray bars) and GRastroKO (blue
bars) mice. Mean ± SEM; **p < 0.01 compared to CTRL NAL; #p<0.05
compared to respective SAL group; n= 13 (CTRL SAL), 12 (CTRL MOR),
19 (CTRL NAL), 14 (GRastroKO SAL), 17 (GRastroKO MOR), 14 (GRastroKO
NAL); two-way ANOVA type 3 followed by Bonferroni post-hoc test
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experience-dependent synaptic plasticity by providing
metabolic support46, and secreting neurotrophic and
synaptogenic factors, as well as gliotransmitters47,48.
Several of potent synaptic effectors are known to undergo
GR regulation, including ATP released from astrocytes
(through activation of SGK149), glial glutamate transpor-
ters25,50 or connexin-3021, which shapes synaptic trans-
mission relevant for hippocampus-dependent contextual
memory51. It is also tempting to speculate that astrocytes
are the site of convergence of noradrenergic52 and GCs
crosstalk, required for fear memory consolidation53.
Our discovery of the speciﬁc function of SGK1 in
astrocytes may be of clinical signiﬁcance. The levels of
SGK1 are decreased in patients suffering from PTSD or
depression31,32, which prompted investigation of the role
of this protein in reorganization of neuronal connectivity.
5xFS
Sgk1_001
Naive
Sgk1_002 Sgk1_003B
C
** **
0
50
100
150
200
LV−shCtrl LV−shSgk1
Lactate release
Veh Dex Veh Dex
** ns
0
100
200
300
%
 L
V
-s
hC
trl
 V
eh
Glucose uptake
Veh Dex Veh Dex
LV−shCtrl LV−shSgk1
* *
0
50
100
150
Glycogen content
Veh Dex Veh Dex
LV−shCtrl LV−shSgk1
Sg
k1
_0
01
Pd
k4
Slc
2a
1
Hk
1
Ld
ha
fo
ld
 D
E
X
 / 
S
A
L
2h 4h
A
Control
GRastroKO
*
0
1
2
3
4
5
6
* *
0
1
2
3
4
5
6
Sg
k1
_0
01
Pd
k4
Slc
2a
1
Hk
1
Ld
ha
**
0
0.1
0.2
0.3
0.4
re
la
tiv
e 
to
 H
pr
t
0
0.05
0.10
0.15
0.20
*
0
0.01
0.02
0.03
5xFSNaive 5xFSNaive
Astrocytes
CTRL/GRastroKO
DEX
C57Bl/6J
Fig. 4 Glucocorticoid signaling regulates metabolic status of astrocytes. a Abundance of indicated transcripts in puriﬁed astrocytes obtained
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However, SGK1 isoforms acquire cell type-speciﬁc
expression proﬁle40,54 with the GR-responsive element
present upstream of glial, but not neuronal isoforms26.
Consequently, our observation of GR-dependent upre-
gulation of glial, but not neuronal isoform in vivo matches
previous data where GC-dependent upregulation of Sgk1
transcript and protein was demonstrated in astrocytes,
microglia and oligodendrocytes, but not in neu-
rons26,49,55,56. These data highlight the need of investi-
gating the function of stress-induced proteins in the
context of the relevant cellular locus.
Our data support the notion that GR stimulation
induces expression of Sgk1 which regulates glucose
uptake. We hypothesize that this control is exerted
through a mechanism involving regulation of the glucose
transporter expression (as suggested by our data, Fig. 4a)
and/or distribution (as shown previously in kidney
cells57). This effect may be engaged in GC-induced
alteration of glucose consumption58, with further impli-
cations for stress-induced memory formation59. Our data
indicate that ablation of GR in astrocytes disrupts this
signaling pathway and may explain the negative impact of
the mutation on the aversive memory.
In summary, we discovered that GR signaling in astro-
cytes is an important part of central effects of stress
exerted by GCs. Our data open new pathways of search
for more efﬁcient therapies of stress-related disorders,
focused on astrocytes as the cellular target.
After completing the manuscript we found that the
same transgenic mouse model was used in the study60.
These authors investigated the role of glucocorticoid
receptor signaling in astrocytes in a mouse model of
armacologically-induced dopaminergic neurons
degeneration.
Acknowledgements
This work was supported by grants from the National Centre of Science to M.S.
(OPUS, 2011/03/B/NZ3/01683) and R.P. (MAESTRO, 013/08/A/NZ3/00848). The
authors would like to express their gratitude to Dr. Frank W. Pfrieger and Dr.
Gunther Schütz for sharing the transgenic lines, to Dr. Steffen Kandler and Dr.
Frank W. Pfrieger for critical and insightful comments on the manuscript, to
Sedef Dalbeyler and Laura Bergauer for help with immunohistochemistry, to
Mgr Maria Kaczmarczyk for help in managing the mouse colony, to Mgr Łukasz
Szumiec for technical help and to Mgr Lidia Radwan for excellent
administrative assistance.
Author details
1Department of Molecular Neuropharmacology, Institute of Pharmacology,
Polish Academy of Sciences, Cracow 31-343, Poland. 2Team Brain Microcircuits
in Psychiatric Diseases, BioMed X Innovation Center, Heidelberg 69120,
Germany. 3Department of Neuroanatomy, Institute of Zoology and Biomedical
Research, Jagiellonian University, Cracow 30-387, Poland
Conﬂict of interest
M.S. and V.D. are employees of BioMed X GmbH where they perform research
on the role of glial cell in psychiatric diseases, sponsored by Boehringer
Ingelheim. Other authors declare that they have no conﬂicts of interest.
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional afﬁliations.
Supplementary Information accompanies this paper at (https://doi.org/
10.1038/s41398-018-0300-x).
Received: 27 April 2018 Revised: 15 September 2018 Accepted: 18 October
2018
References
1. de Kloet, E. R., Joels, M. & Holsboer, F. Stress and the brain: from adaptation to
disease. Nat. Rev. Neurosci. 6, 463–475 (2005).
2. de Quervain, D., Schwabe, L. & Roozendaal, B. Stress, glucocorticoids and
memory: implications for treating fear-related disorders. Nat. Rev. Neurosci. 18,
7–19 (2017).
3. LaBar, K. S. & Cabeza, R. Cognitive neuroscience of emotional memory. Nat.
Rev. Neurosci. 7, 54–64 (2006).
4. Joëls, M. & Baram, T. Z. The neuro-symphony of stress. Nat. Rev. Neurosci. 10,
459–466 (2009).
5. McEwen, B. S. et al. Mechanisms of stress in the brain. Nat. Neurosci. 18,
1353–1363 (2015).
6. Boyle, M. P. et al. Acquired deﬁcit of forebrain glucocorticoid receptor pro-
duces depression-like changes in adrenal axis regulation and behavior. Proc.
Natl. Acad. Sci. USA 102, 473–478 (2005).
7. Boyle, M. P., Kolber, B. J., Vogt, S. K., Wozniak, D. F. & Muglia, L. J. Forebrain
glucocorticoid receptors modulate anxiety-associated locomotor activation
and adrenal responsiveness. J. Neurosci. 26, 1971–1978 (2006).
8. Tronche, F. et al. Disruption of the glucocorticoid receptor gene in the ner-
vous system results in reduced anxiety. Nat. Gen. 23, 99–103 (1999).
9. Wei, Q. et al. Glucocorticoid receptor overexpression in forebrain: a mouse
model of increased emotional lability. Proc. Natl. Acad. Sci. USA 101,
11851–11856 (2004).
10. Joëls, M., Sarabdjitsingh, R. A. & Karst, H. Unraveling the time domains of
corticosteroid hormone inﬂuences on brain activity: rapid, slow, and chronic
modes. Pharmacol. Rev. 64, 901–938 (2012).
11. Mongrain, V. et al. Separating the contribution of glucocorticoids and wake-
fulness to the molecular and electrophysiological correlates of sleep home-
ostasis. Sleep 33, 1147–1157 (2010).
12. Schatzberg, A. F. et al. HPA axis genetic variation, cortisol and psychosis in
major depression. Mol. Psychiatry 19, 220–227 (2014).
13. van Rossum, E. F. et al. Polymorphisms of the glucocorticoid receptor gene
and major depression. Biol. Psychiatry 59, 681–688 (2006).
14. Carrillo-Roa, T. et al. Common genes associated with antidepressant response
in mouse and man identify key role of glucocorticoid receptor sensitivity. PLoS
Biol. 15, e2002690 (2017).
15. Barik, J. et al. Chronic sress triggers social aversion via glucococorticoid
receptor in dopaminoceptive neurons. Science 339, 332–335 (2013).
16. Fitzsimons, C. P. et al. Knockdown of the glucocorticoid receptor alters
functional integration of newborn neurons in the adult hippocampus and
impairs fear-motivated behavior. Mol. Psychiatry 18, 993–1005 (2013).
17. Hartmann, J. et al. Forebrain glutamatergic, but not GABAergic, neurons
mediate anxiogenic effects of the glucocorticoid receptor. Mol. Psychiatry 22,
466–475 (2017).
18. Kolber, B. J. et al. Central amygdala glucocorticoid receptor action promotes
fear-associated CRH activation and conditioning. Proc. Natl. Acad. Sci. USA 105,
12004–12009 (2008).
19. Korostynski, M. et al. Novel drug-regulated transcriptional networks in brain
reveal pharmacological properties of psychotropic drugs. BMC Genom. 14, 606
(2013).
20. Allaman, I., Pellerin, L. & Magistretti, P. J. Glucocorticoids modulate
neurotransmitter-induced glycogen metabolism in cultured cortical astrocytes.
J. Neurochem. 88, 900–908 (2004).
21. Carter, B. S., Meng, F. & Thompson, R. C. Glucocorticoid treatment of astrocytes
results in temporally dynamic transcriptome regulation and astrocyte-
enriched mRNA changes in vitro. Physiol. Genom. 44, 1188–1200 (2012).
22. Doyle, J. P. et al. Application of a translational proﬁling approach for the
comparative analysis of CNS cell types. Cell 135, 749–762 (2008).
Tertil et al. Translational Psychiatry           (2018) 8:255 Page 10 of 11
23. Piechota, M. et al. Transcriptional signatures of steroid hormones in the striatal
neurons and astrocytes. BMC Neurosci 18, 37 (2017).
24. Simard, M. et al. Glucocorticoids-potent modulators of astrocytic calcium
signaling. Glia 28, 1–12 (1999).
25. Zschocke, J. et al. Differential promotion of glutamate transporter expression
and function by glucocorticoids in astrocytes from various brain regions. J. Biol.
Chem. 280, 34924–34932 (2005).
26. Slezak, M. et al. Astrocytes are a neural target of morphine action via gluco-
corticoid receptor-dependent signaling. Glia 61, 623–635 (2013).
27. Carter, B. S., Hamilton, D. E. & Thompson, R. C. Acute and chronic gluco-
corticoid treatments regulate astrocyte-enriched mRNAs in multiple brain
regions in vivo. Front. Neurosci. 7, 139 (2013).
28. Alberini, C. M., Cruz, E., Descalzi, G., Bessieres, B. & Gao, V. Astrocyte glycogen
and lactate: new insights into learning and memory mechanisms. Glia 66,
1244–1262 (2018).
29. Jouroukhin, Y. et al. DISC1 regulates lactate metabolism in astrocytes: impli-
cations for psychiatric disorders. Transl. Psychiatry 8, 76 (2018).
30. Dienel, G. A. The metabolic trinity, glucose-glycogen-lactate, links astrocytes
and neurons in brain energetics, signaling, memory, and gene expression.
Neurosci. Lett. 637, 18–25 (2017).
31. Licznerski, P. et al. Decreased SGK1 expression and function contributes to
behavioral deﬁcits induced by traumatic stress. PLoS Biol. 13, 1–18 (2015).
32. Yuen, E. Y. et al. Mechanisms for acute stress-induced enhancement of glu-
tamatergic transmission and working memory. Mol. Psychiatry 16, 156–170
(2010).
33. Pugh, C. R., Tremblay, D., Fleshner, M. & Rudy, J. W. A selective role for
corticosterone in contextual-fear conditioning. Behav. Neurosci. 111, 503–511
(1997).
34. Deroche-Gamonet, V. et al. The glucocorticoid receptor as a potential target to
reduce cocaine abuse. J. Neurosci. 23, 4785–4790 (2003).
35. Garcia-Perez, D. et al. Different contribution of glucocorticoids in the baso-
lateral amygdala to the formation and expression of opiate withdrawal-
associated memories. Psychoneuroendocrinology 74, 350–362 (2016).
36. Slezak, M. et al. Transgenic mice for conditional gene manipulation in astro-
glial cells. Glia 55, 1565–1576 (2007).
37. Saab, A. S. et al. Bergmann glial AMPA receptors are required for ﬁne motor
coordination. Science 337, 749–753 (2012).
38. Szklarczyk, K. et al. Endogenous opioids regulate glucocorticoid-dependent
stress-coping strategies in mice. Neuroscience 330, 121–137 (2016).
39. Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis.
Nat. Meth. 9, 676–682 (2012).
40. Arteaga, M. F., Alvarez de la Rosa, D., Alvarez, J. A. & Canessa, C. M. Multiple
translational isoforms give functional speciﬁcity to serum- and glucocorticoid-
induced kinase 1. Mol. Biol. Cell 18, 2072–2080 (2007).
41. Popoli, M., Yan, Z., McEwen, B. S. & Sanacora, G. The stressed synapse: the
impact of stress and glucocorticoids on glutamate transmission. Nat. Rev.
Neurosci. 13, 22–37 (2011).
42. Wiltgen, B. J. Context fear learning in the absence of the hippocampus. J.
Neurosci. 26, 5484–5491 (2006).
43. Donley, M. P., Schulkin, J. & Rosen, J. B. Glucocorticoid receptor antagonism in
the basolateral amygdala and ventral hippocampus interferes with long-term
memory of contextual fear. Behav. Brain Res. 164, 197–205 (2005).
44. Ambroggi, F. et al. Stress and addiction: glucocorticoid receptor in dopami-
noceptive neurons facilitates cocaine seeking. Nat. Neurosci. 12, 247–249
(2009).
45. Johansen Joshua, P., Cain Christopher, K., Ostroff Linnaea, E. & LeDoux Joseph,
E. Molecular mechanisms of fear learning and memory. Cell 147, 509–524
(2011).
46. Suzuki, A. et al. Astrocyte-neuron lactate transport is required for long-term
memory formation. Cell 144, 810–823 (2011).
47. Araque, A. et al. Gliotransmitters travel in time and space. Neuron 81, 728–739
(2014).
48. Allen, N. J. & Eroglu, C. Cell biology of astrocyte-synapse interactions. Neuron
96, 697–708 (2017).
49. Koyanagi, S. et al. Glucocorticoid regulation of ATP release from spinal
astrocytes underlies diurnal exacerbation of neuropathic mechanical allodynia.
Nat. Commun. 7, 13102–13102 (2016).
50. Tian, G. et al. Translational control of glial glutamate transporter EAAT2
expression. J. Biol. Chem. 282, 1727–1737 (2007).
51. Pannasch, U. et al. Connexin 30 sets synaptic strength by controlling astroglial
synapse invasion. Nat. Neurosci. 17, 549–558 (2014).
52. Gao, V. et al. Astrocytic beta2-adrenergic receptors mediate hippocampal
long-term memory consolidation. Proc. Natl. Acad. Sci. USA 113, 8526–8531
(2016).
53. Krugers, H. J., Karst, H. & Joels, M. Interactions between noradrenaline and
corticosteroids in the brain: from electrical activity to cognitive performance.
Front. Cell. Neurosci. 6, 15 (2012).
54. Simon, P. et al. Differential regulation of serum- and glucocorticoid-inducible
kinase 1 (SGK1) splice variants based on alternative initiation of transcription.
Cell. Physiol. Biochem. 20, 715–728 (2007).
55. Hinds, L. R. et al. Dynamic glucocorticoid-dependent regulation of Sgk1
expression in oligodendrocytes of adult male rat brain by acute stress and
time of day. PLoS ONE 12, 1–17 (2017).
56. Miyata, S. et al. Plasma corticosterone activates SGK1 and induces morpho-
logical changes in oligodendrocytes in corpus callosum. PLoS ONE 6, e19859
(2011).
57. Palmada, M. et al. SGK1 kinase upregulates GLUT1 activity and plasma
membrane expression. Diabetes 55, 421–427 (2006).
58. Lovallo, W. R., Robinson, J. L., Glahn, D. C. & Fox, P. T. Acute effects of
hydrocortisone on the human brain: an fMRI study. Psychoneuroendocrinology
35, 15–20 (2010).
59. Osborne, D. M., Pearson-Leary, J. & McNay, E. C. The neuroenergetics of stress
hormones in the hippocampus and implications for memory. Front. Neurosci.
9, 164 (2015).
60. Maatouk et al. Glucocorticoid receptor in astrocytes regulates midbrain
dopamine neurodegeneration through connexin hemichannel activity. Cell
Death & Differentiation. (2018). https://doi.org/10.1038/s41418-018-0150-3.
Tertil et al. Translational Psychiatry           (2018) 8:255 Page 11 of 11
